CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling
Author:
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference32 articles.
1. Global cancer statistics 2012;Torre;CA - Cancer J. Clin.,2015
2. Loco-regional treatment of hepatocellular carcinoma;Lencioni;Hepatology,2010
3. The cancer stem cell: premises, promises and challenges;Clevers;Nat. Med.,2011
4. Cancer stem cells: current status and evolving complexities;Visvader;Cell Stem Cell,2012
5. 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit;Zhao;Cancer Cell,2013
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Epigenetic control of immunoevasion in cancer stem cells;Trends in Cancer;2024-09
2. Signaling molecules in the microenvironment of hepatocellular carcinoma;Functional & Integrative Genomics;2024-08-29
3. The Dual Roles of the CXCL10-CXCR3 Axis and Its Therapeutic Potential in Osteosarcoma;2024-06-06
4. A meta-analysis evaluating the role of calcium channel alpha-2 delta-1 subunit in carcinogenesis;International Journal of Scientific Reports;2024-03-28
5. CACNA2D1 regulates the progression and influences the microenvironment of colon cancer;Journal of Gastroenterology;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3